Correlation Between Serum Uric Acid Level and Central Body Fat Distribution in Patients with Type 2 Diabetes

References

• Wang J, Chen RP, Lei L, et al. Prevalence and determinants of hyperuricemia in type 2 diabetes mellitus patients with central obesity in Guangdong Province in China. Asia Pac J Clin Nutr. 2013;22(4):590–598. doi:10.6133/apjcn.2013.22.4.16
   PubMed Web of Science ®Google Scholar
• Juraschek SP, McAdams-Demarco M, Miller ER, et al. Temporal relationship between uric acid concentration and risk of diabetes in a community-based study population. Am J Epidemiol. 2014;179(6):684–691. doi:10.1093/aje/kwt320
   PubMed Web of Science ®Google Scholar
• Jia Z, Zhang X, Kang S, Wu Y. Serum uric acid levels and incidence of impaired fasting glucose and type 2 diabetes mellitus: a meta-analysis of cohort studies. Diabetes Res Clin Pract. 2013;101(1):88–96. doi:10.1016/j.diabres.2013.03.026
   PubMed Web of Science ®Google Scholar
• Sluijs I, Beulens JW, van der A DL, Spijkerman AM, Schulze MB, van der Schouw YT. Plasma uric acid is associated with increased risk of type 2 diabetes independent of diet and metabolic risk factors. J Nutr. 2013;143(1):80–85. doi:10.3945/jn.112.167221
   PubMedGoogle Scholar
• Kodama S, Saito K, Yachi Y, et al. Association between serum uric acid and development of type 2 diabetes. Diabetes Care. 2009;32(9):1737–1742. doi:10.2337/dc09-0288
   PubMed Web of Science ®Google Scholar
• Xu Y, Zhu J, Gao L, et al. Hyperuricemia as an independent predictor of vascular complications and mortality in type 2 diabetes patients: a meta-analysis. PLoS One. 2013;8(10):e78206. doi:10.1371/journal.pone.0078206
   PubMed Web of Science ®Google Scholar
• Jiao Z, gao H, li H, et al. Correlation analysis of hyperuricemia in prediabetes. Chin J Epidemiol. 2013;34(7):725–727.
   Google Scholar
• Krishnan E, Pandya BJ, Chung L, Hariri A, Dabbous O. Hyperuricemia in young adults and risk of insulin resistance, prediabetes, and diabetes: a 15-year follow-up study. Am J Epidemiol. 2012;176(2):108–116. doi:10.1093/aje/kws002
   PubMed Web of Science ®Google Scholar
• Sautin YY, Nakagawa T, Zharikov S, Johnson RJ. Adverse effects of the classic antioxidant uric acid in adipocytes: NADPH oxidase-mediated oxidative/nitrosative stress. Am J Physiol Cell Physiol. 2007;293(2):C584–96. doi:10.1152/ajpcell.00600.2006
   PubMed Web of Science ®Google Scholar
• Tsushima Y, Nishizawa H, Tochino Y, et al. Uric acid secretion from adipose tissue and its increase in obesity. J Biol Chem. 2013;288(38):27138–27149. doi:10.1074/jbc.M113.485094
   PubMed Web of Science ®Google Scholar
• Liu Q, Xiao XH. Subcutaneous adipose tissue and visceral adipose tissue. Int J Pathol Clin. 2013;(06):544–547.
   Google Scholar
• Lima-Martínez MM, Blandenier C, Iacobellis G. Epicardial adipose tissue: more than a simple fat deposit? Endocrinol Nutr. 2013;60(6):320–328. doi:10.1016/j.endonu.2012.08.001
   PubMedGoogle Scholar
• Girard J, Lafontan M. Impact of visceral adipose tissue on liver metabolism and insulin resistance. Part II: visceral adipose tissue production and liver metabolism. Diabetes Metab. 2008;34(5):439–445. doi:10.1016/j.diabet.2008.04.002
   PubMed Web of Science ®Google Scholar
• Bhole V, Choi JW, Kim SW, de Vera M, Choi H. Serum uric acid levels and the risk of type 2 diabetes: a prospective study. Am J Med. 2010;123(10):957–961. doi:10.1016/j.amjmed.2010.03.027
   PubMed Web of Science ®Google Scholar
• Culafic M, Vezmar Kovacevic S, Dopsaj V, et al. A simple index for nonalcoholic steatohepatitis-HUFA-based on routinely performed blood tests. Medicina. 2019;55(6):243.
   PubMedGoogle Scholar
• Darmawan G, Hamijoyo L, Hasan I. Association between serum uric acid and non-alcoholic fatty liver disease: a meta-analysis. Acta Med Indones. 2017;49(2):136–147.
   PubMed Web of Science ®Google Scholar
• Liu CQ, He CM, Chen N, et al. Serum uric acid is independently and linearly associated with risk of nonalcoholic fatty liver disease in obese Chinese adults. Sci Rep. 2016;6:38605. doi:10.1038/srep38605
   PubMed Web of Science ®Google Scholar
• Yang YT, Hwan JJ, Cheol BJ, et al. Metabolism. 2016;4.
   Google Scholar
• Cortese F, Giordano P, Scicchitano P, et al. Uric acid: from a biological advantage to a potential danger. A focus on cardiovascular effects. Vascul Pharmacol. 2019;120:106565. doi:10.1016/j.vph.2019.106565
   PubMed Web of Science ®Google Scholar
• De Pergola G, Cortese F, Termine G, et al. Uric acid, metabolic syndrome and atherosclerosis: the chicken or the egg, which comes first? Endocr Metab Immune Disord Drug Targets. 2018;18(3):251–259. doi:10.2174/1871530318666180212101548
   PubMedGoogle Scholar
• Zupo R, Castellana F, Boninfante B, et al. Uric acid and potassium serum levels are independent predictors of blood pressure non-dipping in overweight or obese Subjects. Nutrients. 2019;11(12):pii: E2970. doi:10.3390/nu11122970
   PubMedGoogle Scholar
• Chinese association of physicians in nephrology. Guidelines for the diagnosis and treatment of renal hyperuricemia in China (2017 edition). Chin Med J. 2017;97(25):1927–1936.
   Google Scholar
• Kaul S, Rothney MP, Peters DM, et al. Dual-energy X-ray absorptiometry for quantification of visceral fat. Obesity. 2012;20(6):1313–1318. doi:10.1038/oby.2011.393
   PubMed Web of Science ®Google Scholar
• Kang SM, Yoon JW, Ahn HY, et al. Android fat depot is more closely associated with metabolic syndrome than abdominal visceral fat in elderly people. PLoS One. 2011;6(11):e27694. doi:10.1371/journal.pone.0027694
   PubMed Web of Science ®Google Scholar
• Seyed-Sadjadi N, Berg J, Bilgin AA, Grant R. Visceral fat mass: is it the link between uric acid and diabetes risk. Lipids Health Dis. 2017;16(1):142. doi:10.1186/s12944-017-0532-4
   PubMedGoogle Scholar
• Levey AS, Bosch JP, Lewis JB, Greene T, Rogers N, Roth D. A more accurate method to estimate glomerular filtration rate from serum creatinine: a new prediction equation. Modification of diet in renal disease study group. Ann Intern Med. 1999;130(6):461–470. doi:10.7326/0003-4819-130-6-199903160-00002
   PubMed Web of Science ®Google Scholar
• Matthews DR, Hosker JP, Rudenski AS, Naylor BA, Treacher DF, Turner RC. Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia. 1985;28(7):412–419. doi:10.1007/BF00280883
   PubMed Web of Science ®Google Scholar
• He XX, Ma XJ, Ying LW, et al. Characteristics of islet cell function and insulin sensitivity in prediabetic population under new diagnostic criteria. J Shanghai jiao Tong Univ. 2018;38(08):941–947+940.
   Google Scholar
• Li L, Yang C, Zhao Y, Zeng X, Liu F, Fu P. Is hyperuricemia an independent risk factor for new-onset chronic kidney disease? A systematic review and meta-analysis based on observational cohort studies. BMC Nephrol. 2014;15:122. doi:10.1186/1471-2369-15-122
   PubMed Web of Science ®Google Scholar
• VanderWeele TJ. A three-way decomposition of a total effect into direct, indirect, and interactive effects. Epidemiology. 2013;24(2):224–232. doi:10.1097/EDE.0b013e318281a64e
   PubMed Web of Science ®Google Scholar
• VanderWeele TJ. Mediation and mechanism. Eur J Epidemiol. 2009;24(5):217–224. doi:10.1007/s10654-009-9331-1
   PubMed Web of Science ®Google Scholar
• Preacher KJ, Hayes AF. Asymptotic and resampling strategies for assessing and comparing indirect effects in multiple mediator models. Behav Res Methods. 2008;40(3):879–891. doi:10.3758/BRM.40.3.879
   PubMed Web of Science ®Google Scholar
• Han T, Meng X, Shan R, et al. Temporal relationship between hyperuricemia and obesity, and its association with future risk of type 2 diabetes. Int J Obes. 2018;42(7):1336–1344. doi:10.1038/s41366-018-0074-5
   PubMed Web of Science ®Google Scholar
• Yamada A, Sato KK, Kinuhata S, et al. Association of visceral fat and liver fat with hyperuricemia. Arthritis Care Res. 2016;68(4):553–561. doi:10.1002/acr.22729
   PubMed Web of Science ®Google Scholar
• Kim TH, Lee SS, Yoo JH, et al. The relationship between the regional abdominal adipose tissue distribution and the serum uric acid levels in people with type 2 diabetes mellitus. Diabetol Metab Syndr. 2012;4(1):3. doi:10.1186/1758-5996-4-3
   PubMedGoogle Scholar
• Tamba S, Nishizawa H, Funahashi T, et al. Relationship between the serum uric acid level, visceral fat accumulation and serum adiponectin concentration in Japanese men. Intern Med. 2008;47(13):1175–1180. doi:10.2169/internalmedicine.47.0603
   PubMed Web of Science ®Google Scholar
• Lanaspa MA, Sanchez-Lozada LG, Choi YJ, et al. Uric acid induces hepatic steatosis by generation of mitochondrial oxidative stress: potential role in fructose-dependent and -independent fatty liver. J Biol Chem. 2012;287(48):40732–40744. doi:10.1074/jbc.M112.399899
   PubMed Web of Science ®Google Scholar
• Kahl S, Gancheva S, Straßburger K, et al. Empagliflozin effectively lowers liver fat content in well-controlled type 2 diabetes: a randomized, double-blind, phase 4, placebo-controlled trial. Diabetes Care. 2020;43:298–305.
   PubMed Web of Science ®Google Scholar
• Blouin K, Boivin A, Tchernof A. Androgens and body fat distribution. J Steroid Biochem Mol Biol. 2008;108(3–5):272–280. doi:10.1016/j.jsbmb.2007.09.001
   PubMed Web of Science ®Google Scholar
• Antón FM, García Puig J, Ramos T, González P, Ordás J. Sex differences in uric acid metabolism in adults: evidence for a lack of influence of estradiol-17 beta (E2) on the renal handling of urate. Metabolism. 1986;35(4):343–348. doi:10.1016/0026-0495(86)90152-6
   PubMed Web of Science ®Google Scholar
• Jiao Z, Gao HL, Li H, et al. Pre-diabetes mellitus influenced by hyperuricemia. Zhonghua Liu Xing Bing Xue Za Zhi. 2013;34(7):725–727.
   PubMedGoogle Scholar
• Zhu Y, Hu Y, Huang T, et al. High uric acid directly inhibits insulin signalling and induces insulin resistance. Biochem Biophys Res Commun. 2014;447(4):707–714. doi:10.1016/j.bbrc.2014.04.080
   PubMed Web of Science ®Google Scholar
• King C, Lanaspa MA, Jensen T, Tolan DR, Sánchez-Lozada LG, Johnson RJ. Uric acid as a cause of the metabolic syndrome. Contrib Nephrol. 2018;192:88–102.
   PubMed Web of Science ®Google Scholar
• Törn C, Landin-Olsson M, Lernmark A, et al. Prognostic factors for the course of beta cell function in autoimmune diabetes. J Clin Endocrinol Metab. 2000;85(12):4619–4623. doi:10.1210/jcem.85.12.7065
   PubMedGoogle Scholar
• Li X, Zhou ZG, Qi HY, et al. Replacement of insulin by fasting C-peptide in modified homeostasis model assessment to evaluate insulin resistance and islet β cell function. J Cent South Univ. 2004;29(4):419–423.
   Google Scholar
• Campos R, Masquio D, Corgosinho FC, et al. Effects of magnitude of visceral adipose tissue reduction: impact on insulin resistance, hyperleptinemia and cardiometabolic risk in adolescents with obesity after long-term weight-loss therapy. Diab Vasc Dis Res. 2019;16(2):196–206. doi:10.1177/1479164118825343
   PubMedGoogle Scholar
• Yoo HG, Lee SI, Chae HJ, Park SJ, Lee YC, Yoo WH. Prevalence of insulin resistance and metabolic syndrome in patients with gouty arthritis. Rheumatol Int. 2011;31(4):485–491. doi:10.1007/s00296-009-1304-x
   PubMed Web of Science ®Google Scholar
• Mazidi M, Katsiki N, Mikhailidis DP, Banach M. The link between insulin resistance parameters and serum uric acid is mediated by adiposity. Atherosclerosis. 2018;270:180–186. doi:10.1016/j.atherosclerosis.2017.12.033
   PubMed Web of Science ®Google Scholar
• Baldwin W, McRae S, Marek G, et al. Hyperuricemia as a mediator of the proinflammatory endocrine imbalance in the adipose tissue in a murine model of the metabolic syndrome. Diabetes. 2011;60(4):1258–1269. doi:10.2337/db10-0916
   PubMed Web of Science ®Google Scholar
• Cheung AS, de Rooy C, Hoermann R, et al. Correlation of visceral adipose tissue measured by Lunar Prodigy dual X-ray absorptiometry with MRI and CT in older men. Int J Obes. 2016;40(8):1325–1328. doi:10.1038/ijo.2016.50
   Google Scholar